Prosecution Insights
Last updated: April 19, 2026

Examiner: SLOUP IV, RUDOLPH EDWARD

Tech Center 1600 • Art Units: 1645

This examiner grants 100% of resolved cases

Performance Statistics

100.0%
Allow Rate
+40.0% vs TC avg
8
Total Applications
-100.0%
Interview Lift
1019
Avg Prosecution Days
Based on 1 resolved cases, 2023–2026

Rejection Statute Breakdown

7.7%
§101 Eligibility
23.1%
§102 Novelty
34.6%
§103 Obviousness
23.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18346128 ANTI-CD8 ANTIBODIES AND USES THEREOF Non-Final OA Genentech, Inc.
18562604 METHOD FOR DETECTING LIVE LACTIC ACID BACTERIA WITH CARBOHYDRATE METABOLISM ACTIVITY Non-Final OA KABUSHIKI KAISHA YAKULT HONSHA
18555429 PESTICIDAL MINICELLS AND COMPOSITIONS THEREOF FOR AGRICULTURAL APPLICATIONS Non-Final OA Invaio Sciences, Inc.
18285011 VACCINE COMPOSITIONS DEPLETING HEMATOPOIETIC GROWTH FACTORS FOR THE TREATMENT OF INFLAMMATORY DISEASES Non-Final OA CENTRO DE INMUNOLOGIA MOLECULAR
18551272 NITRIFYING BACTERIA FORMULATION Non-Final OA JFR CO., LTD.
18277762 LACTOBACILLUS CRISPATUS COMPOSITION FOR USE IN PREGNANT SUBJECTS Non-Final OA Osel, Inc.
18097111 NUTRITIONAL SUPPLEMENTS AND METHODS OF NUTRITIONAL SUPPLEMENTATION AFFECTING WEIGHT LOSS Non-Final OA Amare Global

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month